JAYPIRCA Film-coated tablet Ref.[51528] Active ingredients: Pirtobrutinib

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands

Product name and form

Jaypirca 50 mg film-coated tablets.

Jaypirca 100 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Jaypirca 50 mg film-coated tablets: Blue, 9 × 9 mm, arc-triangle shaped tablet debossed with “Lilly 50” on one side and “6902” on the other side.

Jaypirca 100 mg film-coated tablets: Blue, 10 mm, round tablet debossed with “Lilly 100” on one side and “7026” on the other side.

Qualitative and quantitative composition

Jaypirca 50 mg film-coated tablets

Each film-coated tablet contains 50 mg of pirtobrutinib.

Excipients with known effect: Each film-coated tablet contains 38 mg of lactose (as monohydrate).

Jaypirca 100 mg film-coated tablets

Each film-coated tablet contains 100 mg of pirtobrutinib.

Excipients with known effect: Each film-coated tablet contains 77 mg of lactose (as monohydrate).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pirtobrutinib

Pirtobrutinib is a reversible, noncovalent inhibitor of BTK. BTK is a signalling protein of the B-cell antigen receptor (BCR) and cytokine receptor pathways. In B-cells, BTK signalling results in activation of pathways necessary for B-cell proliferation, trafficking, chemotaxis, and adhesion. Pirtobrutinib binds to wild type BTK as well as BTK harboring C481 mutations leading to inhibition of BTK kinase activity.

List of Excipients

Tablet core:

Hypromellose acetate succinate
Cellulose, microcrystalline
Lactose monohydrate
Croscarmellose sodium
Magnesium stearate
Silica, colloidal hydrated

Film-coating:

Hypromellose
Titanium dioxide
Triacetin
Indigo carmine (E132)

Pack sizes and marketing

Jaypirca 50 mg film-coated tablets: Polyvinylchloride/polychlorotrifluoroethylene blisters sealed with an aluminium foil in packs of 28, 30 or 84 film-coated tablets.

Jaypirca 100 mg film-coated tablets: Polyvinylchloride/polychlorotrifluoroethylene blisters sealed with an aluminium foil in packs of 28, 30, 56, 60, 84 or 168 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands

Marketing authorization dates and numbers

EU/1/23/1738/001
EU/1/23/1738/002
EU/1/23/1738/003
EU/1/23/1738/004
EU/1/23/1738/005
EU/1/23/1738/006
EU/1/23/1738/007
EU/1/23/1738/008
EU/1/23/1738/009

Drugs

Drug Countries
JAYPIRCA Austria, France, Croatia, Ireland, Italy, Lithuania, Romania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.